OBERWEIS ASSET MANAGEMENT INC/

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 937886 LISLE, IL

Position in ARQT

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$32,181,569

+$8,705,633 QoQ

Shares Held

1,365,941

+69.0% QoQ

Ownership

1.09%

of shares outstanding

% of Portfolio

0.95%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Dec 2025

2 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

OBERWEIS ASSET MANAGEMENT INC/ holds $73,946,027 across 4 Biotechnology names. ARQT ranks #1 (43.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARQT	Arcutis Biotherapeutics, Inc. This page	1,365,941	$32,181,569
2	CPRX	Catalyst Pharmaceuticals, Inc.	780,570	$19,326,913
3	HALO	Halozyme Therapeutics, Inc.	219,930	$14,214,075
4	CRMD	CorMedix Inc.	1,211,115	$8,223,470

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$32,181,569	1,365,941	+69.0%	Shares	Sole	2026-05-15
2025-12-31	$23,475,936	808,400	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.